| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1471-0528.2002.01330.X |
| P698 | PubMed publication ID | 12135211 |
| P50 | author | Srdjan Djurovic | Q34568432 |
| P2093 | author name string | Kåre Berg | |
| Frank Brosstad | |||
| Tore Henriksen | |||
| Ragnhild Wergeland | |||
| Torun Clausen | |||
| P2860 | cites work | C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 |
| Pathogenesis and genetics of pre-eclampsia | Q33934445 | ||
| Placental debris, oxidative stress and pre-eclampsia | Q34032003 | ||
| Pre-eclampsia | Q34079933 | ||
| Purification of Moloney murine leukemia virus chromatin from infected cells by an affinity method | Q40802068 | ||
| Cell biology of tissue factor, the principal initiator of blood coagulation | Q41070406 | ||
| Plasma P-selectin is elevated in the first trimester in women who subsequently develop pre-eclampsia | Q43684244 | ||
| P433 | issue | 7 | |
| P921 | main subject | pre-eclampsia | Q61335 |
| inflammation | Q101991 | ||
| P304 | page(s) | 759-764 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | BJOG: an International Journal of Obstetrics and Gynaecology | Q15724571 |
| P1476 | title | Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia | |
| P478 | volume | 109 |
| Q42167645 | Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight |
| Q84770678 | Association of maternal serum high sensitive C‐reactive protein level with body mass index and severity of pre‐eclampsia at third trimester |
| Q54508994 | Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia. |
| Q75212879 | C-reactive protein and body mass index in women with pre-eclampsia |
| Q37019630 | C-reactive protein and preterm delivery: clues from placental findings and maternal weight. |
| Q56794530 | C-reactive protein during normal pregnancy and preeclampsia |
| Q54540772 | C-reactive protein in hypertensive disorders in pregnancy. |
| Q36681260 | C-reactive protein is elevated 30 years after eclamptic pregnancy |
| Q38005760 | Changes in the maternal cytokine profile in pregnancies complicated by fetal growth restriction |
| Q47127911 | Circulating soluble endoglin modifies the inflammatory response in mice. |
| Q45349497 | Correlation of midtrimester amniotic fluid cytokine concentrations with adverse pregnancy outcome in terms of spontaneous abortion, preterm birth, and preeclampsia |
| Q35920782 | Does C-reactive protein predict recurrent preeclampsia? |
| Q28217545 | Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP study |
| Q39016332 | Evidence-Based Revised View of the Pathophysiology of Preeclampsia |
| Q39112949 | First and second trimester immune biomarkers in preeclamptic and normotensive women. |
| Q92819907 | HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients |
| Q47761653 | Interleukin 10-2849AA genotype protects against pre-eclampsia |
| Q27007059 | Is inflammation the cause of pre-eclampsia? |
| Q35888435 | Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction |
| Q37857465 | Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension |
| Q46807493 | Maternal serum inhibin-A for predicting preeclampsia |
| Q36672096 | Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls |
| Q81446389 | Pre-eclampsia |
| Q36572684 | Pre-eclampsia: contribution of maternal constitutional factors and the consequences for cardiovascular health |
| Q21285024 | Preeclampsia 2012 |
| Q36566903 | Prognostic Value of Cardiovascular Disease Risk Factors Measured in the First-Trimester on the Severity of Preeclampsia |
| Q47099455 | The prevalence of elevated high-sensitivity C-reactive protein in normal pregnancy and gestational diabetes mellitus |
| Q26849333 | Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia |
| Q38116097 | Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. |
| Q35161111 | Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm? |
| Q37199643 | Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy |
Search more.